RHÖN-KLINIKUM Aktiengesellschaft (RKAGY)
USD 6.05
(0.0%)
USD 6.05
(0.0%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 149.83 Million EUR | -5.29% |
| 2022 | 158.2 Million EUR | -0.98% |
| 2021 | 159.76 Million EUR | -0.52% |
| 2020 | 160.6 Million EUR | -6.73% |
| 2019 | 172.2 Million EUR | 63.22% |
| 2018 | 105.5 Million EUR | 2605.13% |
| 2017 | 3.9 Million EUR | -71.94% |
| 2016 | 13.9 Million EUR | -91.43% |
| 2015 | 162.2 Million EUR | 1.82% |
| 2014 | 159.3 Million EUR | -80.38% |
| 2013 | 811.8 Million EUR | -21.84% |
| 2012 | 1.03 Billion EUR | 0.0% |
| 2011 | - EUR | 0.0% |
| 2010 | - EUR | 0.0% |
| 2009 | - EUR | -100.0% |
| 2008 | 729.39 Million EUR | 0.0% |
| 2007 | - EUR | 0.0% |
| 2006 | - EUR | 0.0% |
| 2005 | - EUR | 0.0% |
| 2004 | - EUR | -100.0% |
| 2003 | 179.76 Million EUR | -17.91% |
| 2002 | 218.98 Million EUR | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q1 | 143.45 Million EUR | -4.26% |
| 2024 Q2 | 150.86 Million EUR | 5.17% |
| 2023 Q1 | 150.36 Million EUR | -4.95% |
| 2023 Q2 | 8.2 Million EUR | -94.55% |
| 2023 FY | 149.83 Million EUR | -5.29% |
| 2023 Q3 | 150.42 Million EUR | 1734.49% |
| 2023 Q4 | 149.83 Million EUR | -0.39% |
| 2022 Q2 | 157.3 Million EUR | 0.0% |
| 2022 FY | 158.2 Million EUR | -0.98% |
| 2022 Q3 | 150.45 Million EUR | -4.35% |
| 2022 Q4 | 158.2 Million EUR | 5.15% |
| 2022 Q1 | - EUR | -100.0% |
| 2021 Q4 | 159.76 Million EUR | 0.0% |
| 2021 Q1 | - EUR | -100.0% |
| 2021 FY | 159.76 Million EUR | -0.52% |
| 2021 Q3 | - EUR | -100.0% |
| 2021 Q2 | 10.2 Million EUR | 0.0% |
| 2020 FY | 160.6 Million EUR | -6.73% |
| 2020 Q1 | 160.01 Million EUR | -7.08% |
| 2020 Q2 | 160.81 Million EUR | 0.5% |
| 2020 Q3 | 11.5 Million EUR | -92.85% |
| 2020 Q4 | 160.6 Million EUR | 1296.55% |
| 2019 Q2 | 100.64 Million EUR | 0.41% |
| 2019 FY | 172.2 Million EUR | 63.22% |
| 2019 Q1 | 100.23 Million EUR | -4.99% |
| 2019 Q4 | 172.2 Million EUR | 1224.62% |
| 2019 Q3 | 13 Million EUR | -87.08% |
| 2018 Q4 | 105.5 Million EUR | 0.0% |
| 2018 Q1 | - EUR | -100.0% |
| 2018 FY | 105.5 Million EUR | 2605.13% |
| 2018 Q2 | - EUR | 0.0% |
| 2018 Q3 | - EUR | 0.0% |
| 2017 Q3 | - EUR | -100.0% |
| 2017 FY | 3.9 Million EUR | -71.94% |
| 2017 Q4 | 3.9 Million EUR | 0.0% |
| 2017 Q2 | 12.46 Million EUR | -1.87% |
| 2017 Q1 | 12.7 Million EUR | -8.63% |
| 2016 Q3 | 10 Million EUR | -0.01% |
| 2016 Q2 | 10 Million EUR | 0.01% |
| 2016 Q4 | 13.9 Million EUR | 39.0% |
| 2016 FY | 13.9 Million EUR | -91.43% |
| 2016 Q1 | 10 Million EUR | -93.83% |
| 2015 FY | 162.2 Million EUR | 1.82% |
| 2015 Q4 | 162.2 Million EUR | 3.86% |
| 2015 Q3 | 156.16 Million EUR | 0.94% |
| 2015 Q2 | 154.7 Million EUR | 0.94% |
| 2015 Q1 | 153.26 Million EUR | -3.79% |
| 2014 FY | 159.3 Million EUR | -80.38% |
| 2014 Q2 | 164.21 Million EUR | -59.91% |
| 2014 Q1 | 409.56 Million EUR | -49.55% |
| 2014 Q3 | 155.92 Million EUR | -5.05% |
| 2014 Q4 | 159.3 Million EUR | 2.17% |
| 2013 Q1 | 999.07 Million EUR | -3.81% |
| 2013 FY | 811.8 Million EUR | -21.84% |
| 2013 Q4 | 811.8 Million EUR | 2.43% |
| 2013 Q3 | 792.51 Million EUR | -12.66% |
| 2013 Q2 | 907.36 Million EUR | -9.18% |
| 2012 Q1 | - EUR | 0.0% |
| 2012 Q2 | - EUR | 0.0% |
| 2012 Q3 | - EUR | 0.0% |
| 2012 Q4 | 1.03 Billion EUR | 0.0% |
| 2012 FY | 1.03 Billion EUR | 0.0% |
| 2011 Q1 | - EUR | 0.0% |
| 2011 FY | - EUR | 0.0% |
| 2011 Q2 | - EUR | 0.0% |
| 2011 Q3 | - EUR | 0.0% |
| 2011 Q4 | - EUR | 0.0% |
| 2010 Q1 | - EUR | 0.0% |
| 2010 FY | - EUR | 0.0% |
| 2010 Q4 | - EUR | 0.0% |
| 2010 Q3 | - EUR | 0.0% |
| 2010 Q2 | - EUR | 0.0% |
| 2009 FY | - EUR | -100.0% |
| 2009 Q4 | - EUR | 0.0% |
| 2008 FY | 729.39 Million EUR | 0.0% |
| 2007 FY | - EUR | 0.0% |
| 2006 FY | - EUR | 0.0% |
| 2005 FY | - EUR | 0.0% |
| 2004 FY | - EUR | -100.0% |
| 2003 FY | 179.76 Million EUR | -17.91% |
| 2002 FY | 218.98 Million EUR | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| The Amacore Group, Inc. | 2.85 Million USD | -5152.833% |
| Arem Pacific Corporation | 224.41 Thousand USD | -66667.224% |
| Assisted 4 Living, Inc. | 43.05 Thousand USD | -347904.924% |
| BioCorRx Inc. | 5.63 Million USD | -2559.171% |
| Bionik Laboratories Corp. | 2.41 Million USD | -6111.352% |
| Banyan Corp. | 3.65 Million USD | -3994.54% |
| Clearday, Inc. | 45.06 Million USD | -232.501% |
| Dental Patient Care America, Inc. | 27 Thousand USD | -554831.299% |
| Quantum Medical Transport, Inc. | 1097.80 USD | -13648743.141% |
| Empower Clinics Inc. | 2.49 Million USD | -5912.742% |
| First Choice Healthcare Solutions, Inc. | 23.24 Million USD | -544.671% |
| Selectis Health, Inc. | 37.24 Million USD | -302.284% |
| Ethema Health Corporation | 14.58 Million USD | -927.47% |
| HealthLynked Corp. | 1.97 Million USD | -7491.519% |
| HQDA Elderly Life Network Corp. | - USD | -Infinity% |
| Healthcare Solutions Management Group, Inc. | 14.45 Million USD | -936.751% |
| JRSIS Health Care Corporation | 1.02 Million USD | -14448.03% |
| Comjoyful International Company | - USD | -Infinity% |
| Medical Facilities Corporation | 116.21 Million USD | -28.935% |
| MedSmart Group Inc. | 788.04 Thousand USD | -18913.786% |
| North America Frac Sand, Inc. | 275 Thousand USD | -54386.182% |
| Nova Leap Health Corp. | 208.23 Thousand USD | -71854.341% |
| Nexteligent Holdings, Inc. | 1.88 Million USD | -7867.773% |
| PAO Group, Inc. | 639.95 Thousand USD | -23313.86% |
| Primemd Inc. | 7.13 Million USD | -2000.342% |
| Raffles Medical Group Ltd | 65.87 Million USD | -127.453% |
| Ryman Healthcare Limited | 1.53 Billion USD | 90.242% |
| Stem Cell Authority, Ltd. | - USD | -Infinity% |
| SETO Holdings, Inc. | - USD | -Infinity% |
| Optima Medical Innovations Corp. | 1.34 Million USD | -11012.471% |
| Mycotopia Therapies, Inc. | 1.09 Million USD | -13638.309% |
| U.S. NeuroSurgical Holdings, Inc. | 85 Thousand USD | -176178.824% |
| Veltex Corporation | 2.18 Million USD | -6757.962% |
| World Financial Holding Group | 98.4 Thousand USD | -152165.637% |
| Xcelerate Inc. | 1.42 Million USD | -10446.012% |